Aspartame vs Advantame: which is worse?

What is Aspartame?

Aspartame is a low-calorie synthetic dipeptide sweetener composed of two amino acids — phenylalanine and aspartic acid — bonded with methanol. When metabolized, it breaks down into these three components. It is approximately 200 times sweeter than sucrose, so tiny amounts provide significant sweetness with almost no calories.

What is Advantame?

Advantame is the newest FDA-approved synthetic sweetener, approved in 2014. Like neotame, it is a structural derivative of aspartame but with a vanillin-derived substituent. It is approximately 20,000 times sweeter than sucrose — the most potent sweetener currently approved for food use in the US.

Documented risks

Aspartame: Aspartame has been one of the most studied food additives in history, with over 200 regulatory studies reviewed by multiple agencies. The FDA and EFSA have repeatedly reaffirmed its safety at permitted levels for the general population. IARC classification controversy (2023): In July 2023, IARC classified aspartame as Group 2B (possibly carcinogenic to humans), based primarily on limited evidence from human epidemiological studies associating aspartame intake with hepatocellular carcinoma (liver cancer) in some observational studies. Notably, the WHO Joint Expert Committee on Food Additives (JECFA) simultaneously re-evaluated aspartame and maintained the ADI at 40 mg/kg/day, concluding that the evidence does not establish that aspartame causes cancer at typical intake levels. This rare split between IARC (hazard identification) and JECFA (risk assessment) created significant public confusion. Phenylketonuria (PKU): Aspartame is definitively harmful for individuals with phenylketonuria — a genetic disorder affecting phenylalanine metabolism. People with PKU cannot process phenylalanine normally, and aspartame consumption can cause severe neurological damage. This is why all aspartame-containing products must carry a PKU warning on US and EU labels. Methanol release: aspartame metabolism releases methanol (~10% by weight). Critics including independent researcher Woodrow Monte have argued that methanol from aspartame is harmful, citing methanol's conversion to formaldehyde and formic acid in the body. However, methanol released from aspartame is a fraction of the methanol obtained from fresh fruit juices, and regulatory agencies consider the amounts released too small to be clinically significant. Gut microbiome concerns: a 2021 Cell study found that aspartame and other sweeteners altered gut microbiome composition and glucose tolerance in humans. These microbiome effects are an emerging area of research.

Advantame: Advantame is the newest approved high-intensity sweetener with the least post-approval safety data. The FDA approval was based on extensive pre-market animal studies showing no significant toxicity, carcinogenicity, reproductive toxicity, or neurotoxicity at relevant doses. EFSA approved it for EU use in 2014, finding no safety concerns based on the submitted data. Like other synthetic sweeteners, advantame has not been studied for long-term effects in large human populations post-approval. The same gut microbiome and glucose tolerance concerns raised for other sweeteners (aspartame, sucralose, acesulfame K) have not been specifically studied for advantame, though the class-wide concerns are relevant. Given its 2014 approval date, independent long-term safety studies are still limited.